Institutional investors purchased a net $28.4 million shares of BLRX during the quarter ended March 2017 and now own 38.48% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BVF PARTNERS LP Bought 17.5 Million shares of BioLine RX Ltd
SABBY CAPITAL LLC Bought 3.1 Million shares of BioLine RX Ltd
SENVEST MANAGEMENT LLC Bought 3.0 Million shares of BioLine RX Ltd